References
- Lemierre A. On certain septicæmias due to anaerobic organisms. Lancet. 1936;227(5874):701–703. doi:10.1016/S0140-6736(00)57035-4
- Citron DM. Update on the taxonomy and clinical aspects of the genus fusobacterium. Clin Infect Dis. 2002;35(Suppl 1):S22–S27. doi:10.1086/341916
- Hagelskjaer Kristensen L, Prag J. Lemierre’s syndrome and other disseminated Fusobacterium necrophorum infections in Denmark: a prospective epidemiological and clinical survey. Eur J Clin Microbiol Infect Dis. 2008;27(9):779–789. doi:10.1007/s10096-008-0496-4
- Nygren D, Holm K. Invasive infections with Fusobacterium necrophorum including Lemierre’s syndrome: an 8-year Swedish nationwide retrospective study. Clin Microbiol Infect. 2020;26(8):1089.e7–1089.e12. doi:10.1016/j.cmi.2019.12.002
- Lu MD, Vasavada Z, Tanner C. Lemierre syndrome following oropharyngeal infection: a case series. J Am Board Fam Med. 2009;22(1):79–83. doi:10.3122/jabfm.2009.01.070247
- Valerio L, Zane F, Sacco C, et al. Patients with Lemierre syndrome have a high risk of new thromboembolic complications, clinical sequelae and death: an analysis of 712 cases. J Intern Med. 2021;289(3):325–339. doi:10.1111/joim.13114
- Jones C, Siva TM, Seymour FK, O’Reilly BJ. Lemierre’s syndrome presenting with peritonsillar abscess and VIth cranial nerve palsy. J Laryngol Otol. 2006;120(6):502–504. doi:10.1017/S002221510600034X
- Shen MF, Chen HJ. Unilateral proptosis in Lemierre’s syndrome variant. Thorax. 2020;75(9):815–816. doi:10.1136/thoraxjnl-2020-214748
- Osowicki J, Kapur S, Phuong LK, Dobson S. The long shadow of lemierre’s syndrome. J Infect. 2017;74(Suppl 1):S47–S53. doi:10.1016/S0163-4453(17)30191-3
- Li N, Cai Q, Miao Q, Song Z, Fang Y, Hu B. High-throughput metagenomics for identification of pathogens in the clinical settings. Small Methods. 2021;5(1):2000792. doi:10.1002/smtd.202000792
- Klasinc R, Lupyr K, Zeller I, et al. Clinical characteristics of a large cohort of patients with positive culture of Fusobacterium necrophorum. GMS Infect Dis. 2018;6:Doc03. doi:10.3205/id000038
- Lee WS, Jean SS, Chen FL, Hsieh SM, Hsueh PR. Lemierre’s syndrome: a forgotten and re-emerging infection. J Microbiol Immunol Infect. 2020;53(4):513–517. doi:10.1016/j.jmii.2020.03.027
- Johannesen KM, Bodtger U. Lemierre’s syndrome: current perspectives on diagnosis and management. Infect Drug Resist. 2016;9:221–227. doi:10.2147/IDR.S95050
- Moretti M, De Geyter D, Goethal L, Allard SD. Lemierre’s syndrome in adulthood, a case report and systematic review. Acta Clin Belg. 2021;76(4):324–334. doi:10.1080/17843286.2020.1731661
- Riordan T. Human infection with Fusobacterium necrophorum (Necrobacillosis), with a focus on Lemierre’s syndrome. Clin Microbiol Rev. 2007;20(4):622–659. doi:10.1128/CMR.00011-07
- Ge J, Zhou P, Yang Y, Xu T, Yang X. Anticoagulation may contribute to antimicrobial treatment of Lemierre syndrome: a case report. Thromb J. 2021;19(1):80. doi:10.1186/s12959-021-00336-0
- Valerio L, Pleming W, Pecci A, Barco S. Management of Lemierre Syndrome. Minerva Med. 2021;112(6):726–739. doi:10.23736/S0026-4806.21.07497-8